PHAT
Phathom Pharmaceuticals Inc. (PHAT)
NASDAQ · Healthcare
Phathom Pharmaceuticals Inc. annual/quarterly shareholder equity history from 2022 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Phathom Pharmaceuticals Inc. shareholder equity for the quarter ending December 31, 2025 were -438.2M, a 72.79% increase year-over-year.
- Phathom Pharmaceuticals Inc. shareholder equity for 2025 were -438.2M, a 72.79% increase from 2024.
- Phathom Pharmaceuticals Inc. shareholder equity for 2024 were -253.6M, a 248.52% increase from 2023.
- Phathom Pharmaceuticals Inc. shareholder equity for 2023 were -72.8M, a 2.75% decrease from 2022.
- Phathom Pharmaceuticals Inc. shareholder equity for 2022 were -74.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Phathom Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-438 |
| 2024 | $-254 |
| 2023 | $-73 |
| 2022 | $-75 |
| Phathom Pharmaceuticals Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $-438 |
| 2024-12-31 | $-254 |
| 2023-12-31 | $-73 |
| 2022-12-31 | $-75 |
Phathom Pharmaceuticals Inc. Shareholder Equity — FAQ
Phathom Pharmaceuticals Inc. (PHAT) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PHAT's shareholder equity history?
The chart and table above show Phathom Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.